Key takeaways:
Brachytherapy is a type of cancer treatment that places radioactive material into or up against a cancerous tumor.
It can treat many types of cancer, alone or in combination with other therapies.
Brachytherapy is safe and effective, and it has good results in several cancer types.
There are many approaches to cancer treatment. And it can be difficult to know which one may best suit your particular needs. Brachytherapy is a type of radiation therapy for cancer. It involves placing radioactive material into or up against a tumor. Brachytherapy can treat several types of cancer.
Although the use of brachytherapy for certain cancers has gone down over the years, it continues to be an important tool in cancer treatment. In this article, we’ll review different brachytherapy types and techniques. We’ll also discuss common uses of brachytherapy, so you can make an informed decision about your next steps.
There are three main methods to apply brachytherapy. The part of the body and the type of cancer that need treatment help to determine the particular technique. But the goal of all the techniques is the same — deliver a high dose of radiation to cancer cells while avoiding healthy tissues:
Intracavitary brachytherapy: This involves putting an applicator into an opening in the body. A common example is placement of a vaginal cylinder after surgery for uterine cancer.
Interstitial brachytherapy: This involves placing hollow needles into an organ or tissue. A common example is the placement of radioactive “seeds” to treat prostate cancer.
Surface brachytherapy: This involves placing an applicator on the skin to treat skin cancer.
Another variable is the dose rate, which also depends on the type of cancer and body part. This refers to how quickly the radiation dose is delivered:
Low-dose rate (LDR): LDR brachytherapy delivers the dose over days, weeks, or months. Often, the radioactive material is implanted permanently and decays over time.
High-dose rate (HDR): HDR brachytherapy delivers the radiation dose more quickly. It usually takes minutes. The radioactive material is placed in the body and then removed.
Radiation oncologists, doctors trained in radiation therapy, use brachytherapy to treat many different cancers. Some of the most common uses include:
Prostate cancer: Interstitial brachytherapy is a common technique for prostate cancer, with either LDR or HDR. Experts sometimes combine brachytherapy with external beam radiation therapy (EBRT).
Uterine cancer: Brachytherapy can help prevent uterine cancer from coming back after surgery. This is usually HDR treatment with a vaginal cylinder.
Cervical cancer: Intracavitary HDR brachytherapy commonly follows chemotherapy and EBRT.
Breast cancer: Brachytherapy — often with an intracavitary balloon — can help prevent breast cancer from coming back after lumpectomy.
Skin cancer: In some cases, brachytherapy can be an alternative to surgery. This is usually HDR treatment with a surface applicator.
Other cancers: Brachytherapy can also treat rectal cancer, ocular melanoma, and more.
Radiation oncologists perform brachytherapy. They can do some types of brachytherapy in the clinic without anesthesia. Examples include treatment of skin cancer and uterine cancer.
In other cases, they perform brachytherapy in an operating room under anesthesia. For example, interstitial brachytherapy for prostate cancer requires sedation. Similarly, brachytherapy for cervical cancer can also involve sedation.
The first step in treatment is for the provider to place an applicator in the body that needs treatment. Next, the provider loads the applicator with radioactive material. In some cases, the provider removes the radioactive material after treatment. In other cases, the radioactive material stays in the body.
Brachytherapy and external beam radiation therapy (EBRT) are two different forms of radiation treatment. Radiation oncologists deliver both forms. And both are safe and effective treatments.
EBRT most commonly works as an X-ray therapy. A person getting EBRT lies down on a treatment table, and an X-ray machine points a beam at the target.
Brachytherapy usually involves the placement of radioactive material into the body. This is why it’s often referred to as “internal” radiation therapy.
The decision to use brachytherapy or EBRT depends on many factors. For example, the cancer type, stage, and location all play a role in the decision. So each person’s case is different. In some cases, experts combine EBRT and brachytherapy for the best possible results.
Brachytherapy provides excellent results in several cancer types.
In cervical cancer, brachytherapy leads to better survival compared to other radiation techniques.
In prostate cancer, brachytherapy has excellent outcomes in low-risk and intermediate-risk disease. In high-risk prostate cancer, combining EBRT with brachytherapy has better outcomes than EBRT alone.
Treatment for early stage breast cancer includes surgery and then radiation. In these cases, there are similar results with brachytherapy or EBRT.
Brachytherapy works by placing a device in the body, so the device can cause issues at the placement site and surrounding area. For example, side effects from interstitial brachytherapy can include pain or bleeding from the implant.
The radiation can also cause side effects. The side effects from radiation depend on what tissues are nearby. For example, radiation to the pelvis can cause irritation of the rectum or bladder. This can cause symptoms like frequent and urgent urination or diarrhea.
Most side effects get better after a few months. Your treatment team will provide instructions for how to care for them and when to get help. But in some cases, radiation side effects can be long lasting. It’s difficult to predict when this might happen, but dose and location may play a role. Your provider can help you understand your risks before treatment.
In many cancers, increasing the dose of radiation improves the likelihood of having a successful treatment. And brachytherapy can safely deliver higher radiation doses than EBRT.
The use of brachytherapy for some cancers — such as cervical cancer — has decreased over the years. There are some likely reasons for this trend. First, radiation oncology training puts less emphasis on brachytherapy than it did in the past. Also, insurance reimbursement for brachytherapy services has gone down.
Survival rates for cervical cancer have decreased, as well as the use of cervical cancer brachytherapy. This has led some experts to warn that leaving out brachytherapy is inappropriate and can lead to worse outcomes. They believe the higher radiation dose that brachytherapy delivers is an important part of treatment.
There’s a similar trend in prostate cancer, with declining use of brachytherapy over time. This trend is worrisome, particularly given the benefits of prostate brachytherapy in certain cases.
Brachytherapy is an important part of therapy for several types of cancer. There are different types of brachytherapy, which are generally safe and effective. Many factors determine whether brachytherapy may help, so it may not be right for everyone. But it’s important to know about your options when discussing cancer treatment with your care team.
American Brachytherapy Society. (n.d.). Prostate seeds.
American Society for Radiation Oncology. (n.d.). Home.
Andring, L., et al. (2022). PSA: Declining use of prostate brachytherapy. Brachytherapy.
DePolo, J. (2021). Brachytherapy or internal radiation. Breastcancer.org
Gill, B., et al. (2014). National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: The impact of new technological advancements. International Journal of Radiation Oncology, Biology, Physics.
Han, K., et al. (2013). Trends in the utilization of brachytherapy in cervical cancer in the United States. International Journal of Radiation Oncology, Biology, Physics.
Tanderup, K., et al. (2014). Curative radiation therapy for locally advanced cervical cancer: Brachytherapy is NOT optional. International Journal of Radiation Oncology, Biology, Physics
Vicini, F. A., et al. (2019). Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: A randomised, phase 3, equivalence trial. The Lancet.